At least 27 new GLP-1 drugs are currently undergoing trials at various stages, including a triple-hormone-receptor agonist combining GLP-1, GIP and glucagon receptors
In women, the Ovarian-Adrenal-Thyroid (OAT) axis may become unbalanced, producing concurrent symptoms of adrenal strain, estrogen dominance, and subclinical hypothyroidism
Ballooning multinucleated giant cells and eosinophilic inclusion bodies are seen on the Tzanck smear
C., Guerry, D., Elder, D
Pre-mixed injectable glutathione is available from compounding pharmacies, and lyophilized powder requires reconstitution with bacteriostatic water before use
GLP-1RAs offer a multifaceted therapy: improving glycemia, weight, liver steatosis, and histology